Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Zeng

Showing results (381-390 of 484) with videos related to

Pageof 49
Sort By:
Research Square|July 3, 2026
Estrogen-related receptor alpha (ERRα) promotes gastrointestinal stromal tumor progression and epithelial-mesenchymal transition through Wnt/β-cateninRonald DeMatteo, Taylor Hartlein, Shan Zeng, et al.
Journal of Neurotrauma|October 30, 2020
Governor Vessel Electro-Acupuncture Promotes the Intrinsic Growth Ability of Spinal Neurons through Activating Calcitonin Gene-Related Peptide/α-Calcium/Calmodulin-Dependent Protein Kinase/Neurotrophin-3 Pathway after Spinal Cord InjuryHaoyu Xu, Yang Yang, Qing-Wen Deng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 8, 2021
A comprehensive analysis of the efficacy and safety of COVID-19 vaccinesChangjing Cai, Yinghui Peng, Edward Shen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 15, 2011
Opposing roles of RAGE and Myd88 signaling in extensive liver resectionShan Zeng, Qing Yin Zhang, Jianzhong Huang, et al.
Research Square|June 12, 2026
Effector Vδ1 γδT cells mediate anti-tumor immunity and are reprogrammed by imatinib in human gastrointestinal stromal tumorRonald DeMatteo, Shan Zeng, Jonathan Sussman, et al.
Iscience|January 30, 2023
MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinomaQiaoqiao Huang, Ying Han, Edward Shen, et al.
Iscience|July 26, 2024
Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancerYulai Zhou, Xiangyang Zhang, Yan Gao, et al.
Scientific Reports|April 29, 2025
The molecular characteristics of DNA damage and repair related to P53 mutation for predicting the recurrence and immunotherapy response in hepatocellular carcinomaJiayao Ma, Diya Tang, Guangzu Cui, et al.
Journal of Neurosurgery|February 4, 2023
Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignanciesWeijun Wang, Haiping He, Shan Zeng, et al.
Frontiers in Oncology|January 3, 2022
Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination <i>vs.</i> Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1)Lin Wu, Chao Deng, Hui Zhang, et al.
Pageof 49

Showing results (381-390 of 484) with videos related to

Sort By:
Pageof 49
Research Square|July 3, 2026
Estrogen-related receptor alpha (ERRα) promotes gastrointestinal stromal tumor progression and epithelial-mesenchymal transition through Wnt/β-cateninRonald DeMatteo, Taylor Hartlein, Shan Zeng, et al.
Journal of Neurotrauma|October 30, 2020
Governor Vessel Electro-Acupuncture Promotes the Intrinsic Growth Ability of Spinal Neurons through Activating Calcitonin Gene-Related Peptide/α-Calcium/Calmodulin-Dependent Protein Kinase/Neurotrophin-3 Pathway after Spinal Cord InjuryHaoyu Xu, Yang Yang, Qing-Wen Deng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 8, 2021
A comprehensive analysis of the efficacy and safety of COVID-19 vaccinesChangjing Cai, Yinghui Peng, Edward Shen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 15, 2011
Opposing roles of RAGE and Myd88 signaling in extensive liver resectionShan Zeng, Qing Yin Zhang, Jianzhong Huang, et al.
Research Square|June 12, 2026
Effector Vδ1 γδT cells mediate anti-tumor immunity and are reprogrammed by imatinib in human gastrointestinal stromal tumorRonald DeMatteo, Shan Zeng, Jonathan Sussman, et al.
Iscience|January 30, 2023
MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinomaQiaoqiao Huang, Ying Han, Edward Shen, et al.
Iscience|July 26, 2024
Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancerYulai Zhou, Xiangyang Zhang, Yan Gao, et al.
Scientific Reports|April 29, 2025
The molecular characteristics of DNA damage and repair related to P53 mutation for predicting the recurrence and immunotherapy response in hepatocellular carcinomaJiayao Ma, Diya Tang, Guangzu Cui, et al.
Journal of Neurosurgery|February 4, 2023
Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignanciesWeijun Wang, Haiping He, Shan Zeng, et al.
Frontiers in Oncology|January 3, 2022
Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination <i>vs.</i> Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1)Lin Wu, Chao Deng, Hui Zhang, et al.
Pageof 49